Related Experiment Video
Updated: Apr 25, 2026
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Inherited macrothrombocytopenias
David John Rabbolini1, Marie Christine Morel-Kopp1, William Stevenson1
1Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia.
Abstract:
Inherited macrothrombocytopenias are a clinically heterogeneous group of disorders, many of which cause moderate-to-severe bleeding tendencies in affected individuals, but which remain under-recognized and are frequently misdiagnosed as immune thrombocytopenia purpura. Diagnostic strategies to date have included a predominant phenotypic approach. The emergence of genetic testing and the implementation of next generation sequencing strategies in the investigation and diagnosis of these disorders have broadened our understanding of their pathogenesis, classification, and presentation. This review describes the increasingly expanding group of recognized inherited macrothrombocytopenias and highlights their pathophysiology and the role of phenotypic and genetic testing in their description and diagnosis.
Insights
Inherited macrothrombocytopenias cause bleeding but are often misdiagnosed. Genetic testing is improving diagnosis and understanding of these rare platelet disorders.
Area of Science:
- Hematology
- Genetics
- Clinical Medicine
Background:
- Inherited macrothrombocytopenias are rare bleeding disorders.
- These conditions are often misdiagnosed as immune thrombocytopenia purpura.
- Traditional diagnosis relies on phenotypic assessment.
Purpose of the Study:
- To review the expanding classification of inherited macrothrombocytopenias.
- To discuss the pathophysiology of these disorders.
- To highlight the role of genetic testing in diagnosis.
Main Methods:
- Literature review of inherited macrothrombocytopenias.
- Analysis of diagnostic strategies, including phenotypic and genetic testing.
- Discussion of recent advances in next-generation sequencing.
Main Results:
- Inherited macrothrombocytopenias encompass a heterogeneous group of disorders.
- Genetic testing has significantly advanced the understanding of pathogenesis and classification.
- Next-generation sequencing aids in accurate diagnosis.
Conclusions:
- A growing number of inherited macrothrombocytopenias are being identified.
- Integrated phenotypic and genetic testing is crucial for accurate diagnosis.
- Improved diagnostic approaches enhance patient care and understanding of these conditions.
Related Concept Videos
01:24Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:18Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
01:27Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:19Multipotency of Hematopoietic Stem Cells
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:20Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...